SMR vs. RGC
SMR (NuScale Power Corporation) and RGC (Regencell Bioscience Holdings Limited) are both stocks. SMR operates in Specialty Industrial Machinery (Industrials), while RGC operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 3 years, SMR returned 5.43%/yr vs -8.77%/yr for RGC. At a 0.05 correlation, their price movements are largely independent.
Performance
SMR vs. RGC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMR achieves a -30.20% return, which is significantly lower than RGC's -10.33% return.
SMR
- 1D
- 3.34%
- 1M
- -17.31%
- YTD
- -30.20%
- 6M
- -46.07%
- 1Y
- -75.51%
- 3Y*
- 5.43%
- 5Y*
- -0.32%
- 10Y*
- —
RGC
- 1D
- -4.37%
- 1M
- -31.08%
- YTD
- -10.33%
- 6M
- 13.43%
- 1Y
- -96.92%
- 3Y*
- -8.77%
- 5Y*
- —
- 10Y*
- —
SMR vs. RGC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SMR NuScale Power Corporation | -30.20% | -20.97% | 444.98% | -67.93% | 2.29% | 0.30% |
RGC Regencell Bioscience Holdings Limited | -10.33% | 325.10% | -52.95% | -62.35% | -12.43% | 165.42% |
Correlation
The correlation between SMR and RGC is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2021 | 0.05 |
The correlation between SMR and RGC shifts across timeframes, from 0.05 (all time) to 0.20 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
SMR:
$3.16B
RGC:
$9.31B
SMR:
-$2.02
RGC:
-$0.02
SMR:
2.71
RGC:
7.64K
SMR:
$18.10M
RGC:
$0.00
SMR:
$4.45M
RGC:
-$40.84K
SMR:
-$696.20M
RGC:
-$8.81M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMR vs. RGC — Risk / Return Rank
SMR
RGC
SMR vs. RGC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NuScale Power Corporation (SMR) and Regencell Bioscience Holdings Limited (RGC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMR | RGC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.29 | ||
| Sortino ratioReturn per unit of downside risk | -0.88 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 0.95 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | -0.99 | +0.07 |
| Martin ratioReturn relative to average drawdown | -1.32 | -1.01 | -0.31 |
Loading charts...
Drawdowns
SMR vs. RGC - Drawdown Comparison
The maximum SMR drawdown since its inception was -87.47%, smaller than the maximum RGC drawdown of -98.82%. Use the drawdown chart below to compare losses from any high point for SMR and RGC.
Loading charts...
Drawdown Indicators
| SMR | RGC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.47% | -98.82% | +11.35% |
Max Drawdown (1Y)Largest decline over 1 year | -82.86% | -98.26% | +15.40% |
Max Drawdown (3Y)Largest decline over 3 years | -82.86% | -98.82% | +15.96% |
Max Drawdown (5Y)Largest decline over 5 years | -87.47% | — | — |
Current DrawdownCurrent decline from peak | -81.49% | -97.85% | +16.36% |
Average DrawdownAverage peak-to-trough decline | -35.08% | -64.69% | +29.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 57.39% | 96.08% | -38.69% |
Volatility
SMR vs. RGC - Volatility Comparison
NuScale Power Corporation (SMR) has a higher volatility of 28.93% compared to Regencell Bioscience Holdings Limited (RGC) at 19.08%. This indicates that SMR's price experiences larger fluctuations and is considered to be riskier than RGC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMR | RGC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.93% | 19.08% | +9.85% |
Volatility (6M)Calculated over the trailing 6-month period | 69.57% | 109.32% | -39.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 102.59% | 216.12% | -113.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 93.50% | 283.47% | -189.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 89.31% | 283.47% | -194.16% |
Dividends
SMR vs. RGC - Dividend Comparison
Neither SMR nor RGC has paid dividends to shareholders.
Financials
SMR vs. RGC - Financials Comparison
This section allows you to compare key financial metrics between NuScale Power Corporation and Regencell Bioscience Holdings Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SMR and RGC have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMR has higher volatility (28.93%) compared to RGC (19.08%). In terms of maximum drawdown, SMR dropped -87.47% vs RGC's -98.82%.
RGC currently has the higher Sharpe Ratio (-0.45 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMR and RGC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer